Group 1 - The stock price of Jiuyuan Yinhai has increased by 5.75% to 22.99 CNY per share, with a trading volume of 744 million CNY and a turnover rate of 8.45%, resulting in a total market capitalization of 9.385 billion CNY [1] - Jiuyuan Yinhai has experienced a continuous increase in stock price for three consecutive days, with a cumulative increase of 19.45% during this period [1] - The company, established on November 24, 2008, and listed on December 31, 2015, focuses on software products, operation and maintenance services, and system integration in the field of social security and human resources [1] Group 2 - The fund managed by Huatai-PineBridge has a significant holding in Jiuyuan Yinhai, with the Huatai-PineBridge CSI Internet Medical Index (LOF) A (501007) reducing its holdings by 32,380 shares to 423,600 shares, representing 4.89% of the fund's net value [2] - The fund has realized a floating profit of approximately 529,500 CNY today and a total floating profit of 1.4996 million CNY during the three-day stock price increase [2] - The Huatai-PineBridge CSI Internet Medical Index (LOF) A (501007) was established on December 22, 2016, with a current scale of 70.2192 million CNY and a year-to-date return of 14.69%, ranking 327 out of 5,517 in its category [2]

1月12日，久远银海涨5.17%，截至发稿，报21.36元/股，成交6427.44万元，换手率0.74%，总市值87.20 亿元。 资料显示，四川久远银海软件股份有限公司位于四川省成都市三色路163号，成立日期2008年11月24 日，上市日期2015年12月31日，公司主营业务涉及以人力资源和社会保障为核心的民生信息化领域软件 产品、运维服务和系统集成。主营业务收入构成为：运维服务49.40%，软件34.76%，系统集成 15.60%，其他(补充)0.24%。 南方中证1000ETF（512100）基金经理为崔蕾。 截至发稿，崔蕾累计任职时间7年68天，现任基金资产总规模1227.6亿元，任职期间最佳基金回报 234.52%， 任职期间最差基金回报-15.93%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 从久远银海十大流通股东角度 数据显示，南方基金旗下1只基金位居久远银海十大流通股东。南方中证1000ETF（512100）三季度减 持1.6 ...

Group 1 - The family doctor concept index rose by 4.40%, ranking 10th among concept sectors, with 25 stocks increasing in value, including Meinian Health, Jiuyuan Yinhai, and Guoxin Health reaching the daily limit [1] - Notable gainers in the family doctor sector included Weining Health, which increased by 13.79%, Jiao Dian Technology by 9.43%, and Chuangye Huikang by 9.28% [1] - The sector experienced a net outflow of 1.975 billion yuan, with 13 stocks seeing net inflows, and 5 stocks receiving over 100 million yuan in net inflows, led by Keda Xunfei with a net inflow of 536 million yuan [2][3] Group 2 - The top stocks by net inflow ratio in the family doctor concept were Meinian Health at 43.26%, Guoxin Health at 42.77%, and Jiuyuan Yinhai at 24.29% [3] - The family doctor concept's top stocks included Keda Xunfei with a 4.10% increase and a turnover rate of 6.48%, Meinian Health with a 10.05% increase and a turnover rate of 4.37%, and Jiuyuan Yinhai with a 10.02% increase and a turnover rate of 10.61% [3][4] - Other notable stocks included Jiao Dian Technology with a 9.43% increase and a turnover rate of 11.13%, and Guoxin Health with a 10.01% increase and a turnover rate of 2.90% [4]

Core Viewpoint - The DRG/DIP concept has seen a significant increase of 5.67%, ranking third among concept sectors, with 21 stocks rising, including a 20% surge in Di'an Diagnostics, and several other stocks reaching their daily limit up [1][2]. Group 1: Market Performance - The DRG/DIP concept sector experienced a net inflow of 350 million yuan, with 14 stocks receiving net inflows, and 7 stocks attracting over 30 million yuan each [2]. - Di'an Diagnostics led the net inflow with 290 million yuan, followed by Jiuyuan Yinhai and Guoxin Health with net inflows of 206 million yuan and 127 million yuan, respectively [2][3]. Group 2: Stock Performance - The top performers in the DRG/DIP concept included: - Di'an Diagnostics with a 20% increase and a turnover rate of 20.80% [3]. - Jiuyuan Yinhai with a 10.02% increase and a turnover rate of 10.61% [3]. - Guoxin Health with a 10.01% increase and a turnover rate of 2.90% [3]. - Other notable stocks include: - Weining Health with a 13.79% increase and a turnover rate of 18.16% [4]. - Jiahe Meikang with an 11.17% increase and a turnover rate of 13.98% [3].

Core Viewpoint - The A-share market showed strong performance with the Shanghai Composite Index surpassing 4100 points, indicating a potential bullish trend in the market [3][11]. Market Performance - The Shanghai Composite Index rose by 0.92% to close at 4120.43, the Shenzhen Component Index increased by 1.15% to 14120.15, the ChiNext Index gained 0.77% to 3327.81, and the Sci-Tech Innovation Board Index surged by 2.09% to 1803.40 [4][3]. - The total trading volume in the Shanghai and Shenzhen markets reached 3.12 trillion yuan, an increase of 322.4 billion yuan compared to the previous trading day, with over 3900 stocks rising and more than a hundred stocks hitting the daily limit for two consecutive days [8]. Sector Performance - AI application themes surged, particularly in the fields of healthcare, film, and short drama games, with stocks like Meian Health, Jiuyuan Yinhai, and Guoxin Health hitting the daily limit [5][6]. - The concept of controllable nuclear fusion continued to perform strongly, with stocks such as Hongxun Technology and Xiamen Tungsten rising by the daily limit [7]. Fund Flow - Major funds saw net inflows in sectors such as non-ferrous metals, media, and home appliances, while there were net outflows in semiconductor, insurance, and electronic components sectors [10]. - Specific stocks that attracted significant net inflows included Liou Co., Jinfa Technology, and Kunlun Wanwei, with inflows of 1.747 billion yuan, 1.663 billion yuan, and 1.369 billion yuan respectively [10]. Institutional Insights - Dexun Securities noted that the Shanghai Composite Index's rise above 4100 points, coupled with increased trading volume, suggests the potential for a comprehensive bull market [11]. - Guojin Securities emphasized the acceleration of the spring market and the importance of AI chain rotation opportunities, while Xiangcai Securities highlighted the recent upward breakout of the Shanghai Composite Index, indicating a possible recovery of the upward trend from the second half of 2025 [13].

Core Viewpoint - JiuYuan YinHai (SZ002777) reached its daily limit on January 9, 2026, with a price of 20.31 yuan, marking a 10.02% increase, and a total market capitalization of 8.291 billion yuan [1] Group 1: Financial Performance - The company completed fundraising project adjustments, permanently supplementing 158 million yuan to its working capital, significantly improving capital efficiency [2] - In Q3 2025, the net profit attributable to shareholders increased by 151.66% year-on-year, while the non-recurring net profit surged by 492.73%, and the net cash flow from operating activities turned positive, improving by 131.24% year-on-year [2] Group 2: Strategic Focus - JiuYuan YinHai is focusing on three strategic directions: healthcare insurance, digital governance, and smart cities, leveraging big data and cloud computing technologies to empower the livelihood sector [2] - The current market shows high interest in digital economy and healthcare informationization, indicating potential growth in the industry [2] Group 3: Research and Development - The company's R&D investment increased by 48.69% year-on-year, indicating a stronger commitment to technological innovation, which will enhance core competitiveness [2] - Two subsidiaries received recognition as high-tech enterprises, allowing them to enjoy a 15% corporate income tax reduction for the next three years, which will improve overall profitability [2] Group 4: Market Dynamics - Technical analysis suggests that if the MACD indicator forms a golden cross and the stock price breaks through significant resistance levels, market confidence in the stock will increase [2] - On the day of the price surge, if there is significant inflow of institutional funds and high net buying amounts, it will drive the stock price up to the limit [2]

Core Viewpoint - The A-share market shows positive momentum with the Shanghai Composite Index above the annual line, indicating a potential bullish trend in the market [1]. Group 1: Market Performance - As of 10:30 AM today, the Shanghai Composite Index is at 4112.37 points, with a gain of 0.72% [1]. - The total trading volume in the A-share market is 14,306.83 billion yuan [1]. Group 2: Stocks Breaking Annual Line - A total of 110 A-shares have surpassed the annual line today, with notable stocks including: - Zhongcheng Technology with a deviation rate of 12.46% and a price increase of 17.30% [1]. - Weining Health with a deviation rate of 10.62% and a price increase of 11.26% [1]. - Yaxin Security with a deviation rate of 8.21% and a price increase of 10.05% [1]. - Other stocks with smaller deviation rates that have just crossed the annual line include: - Fenghuang Optical, Jialiqi, and Jiechengtong [1].

机构持仓方面，截止2025年9月30日，久远银海十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股305.37万股，相比上期减少156.95万股。金鹰科技创新股票A（001167）位居第四大流通 股东，持股300.00万股，为新进股东。南方中证1000ETF（512100）位居第六大流通股东，持股261.78 万股，相比上期减少1.61万股。易方达新常态混合（001184）退出十大流通股东之列。 责任编辑：小浪快报 1月5日，久远银海盘中上涨2.06%，截至13:43，报18.31元/股，成交9938.23万元，换手率1.36%，总市 值74.75亿元。 资金流向方面，主力资金净流入348.60万元，特大单买入845.32万元，占比8.51%，卖出294.23万元，占 比2.96%；大单买入1119.35万元，占比11.26%，卖出1321.84万元，占比13.30%。 截至11月28日，久远银海股东户数5.56万，较上期减少0.93%；人均流通股7280股，较上期增加0.94%。 2025年1月-9月，久远银海实现营业收入6.87亿元，同比增长2.83%；归母净利润4278.91万元，同比增长 ...

证券代码：002777 证券简称：久远银海 公告编号：2025-048 四川久远银海软件股份有限公司 关于募集资金专户完成销户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 四川久远银海软件股份有限公司（以下简称"公司"）已于近日办理完成了募集资金专项 账户的注销手续，现将具体情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准四川久远银海软件股份有限公司非公开发行股票的 批复》（证监许可【2017】1504 号）核准，公司非公开发行人民币普通股股票（A 股） 12,540,592.00 股，每股面值 1 元，发行价格为人民币 35.72 元/股，募集资金总额为人民币 447,950,000.00 元。扣除承销、保荐及税款等费用后总额为 437,450,000 元，扣除其他发行 费用（律师费用、验资费用、信息披露费用，印花税）后实际募集资金净额人民币 435,863,350.47 元。上述资金到位情况业经立信会计师事务所（特殊普通合伙）验证，并由其出具信会师报字 [2018]第 10044 号验资报告。 二、募集资金存放和管理情况 ...

四川久远银海软件股份有限公司 2025年第二次临时股东会决议的 公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 重要提示 1、本次股东会无增加、变更、否决提案的情况； 2、本次股东会不涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002777 证券简称：久远银海 公告编号：2025-046 4、会议召集人：公司董事会 5、会议主持人：董事长连春华先生 6、本次股东会会议的召集、召开与表决程序符合《公司法》《公司章程》及《股东会议事规则》等有 关法律、法规及规范性法律文件规定。 7、会议出席情况： 出席本次会议的股东及股东授权代表共292人，代表股份165,084,424股，占公司有表决权股份总数的 40.4390%。其中除公司董事、高级管理人员以及单独或者合计持有公司5%以上股份的股东以外的其他 股东（以下简称"中小股东"） 共288人，代表股份3,752,896股，占公司有表决权股份总数的0.9193%。 1、会议召开时间： （1）现场会议时间：2025年12月29日（星期一）下午 ...